Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.
The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...
An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...
Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.
OSA and COPD present with symptoms that often go undetected for too long. How can clinicians recognize symptoms faster?
Angiotensin-converting enzyme (ACE) inhibitor therapy may reduce all-cause mortality in idiopathic pulmonary fibrosis (IPF) but not in COPD.
Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...
Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...
After a diagnosis of idiopathic pulmonary fibrosis at 78, Houghton Hutcheson continues to live his life and chooses not to ...
Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback